Stocks › MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI·Nasdaq·United States United States·USD
$7.85
-0.67 (-7.86%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRVIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of MRVI by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Stock Sale
$1,001 - $15,000
May 19, 2023 Apr 10, 2023 Filing ↗

Whale Activity

Position changes in MRVI reported for 2026-06-30 by 9 tracked institutional filers
Increased: 6Decreased: 2No prior filing: 1
  • Increased6
  • New0
  • Held0
  • Decreased2
  • Closed0
  • No prior filing1
FilerSharesValueChange
GTCR LLC20.2M$125.7M—
BlackRock, Inc.10.0M$62.2Mincreased
MILLENNIUM MANAGEMENT LLC6.5M$40.6Mincreased
VANGUARD CAPITAL MANAGEMENT LLC5.3M$33.0Mdecreased
RENAISSANCE TECHNOLOGIES LLC4.6M$28.7Mincreased
TWO SIGMA INVESTMENTS, LP2.3M$14.1Mincreased
CITADEL ADVISORS LLC2.1M$13.2Mincreased
Point72 Asset Management, L.P.2.0M$12.5Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC1.1M$6.7Mincreased

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by MRVI insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -25.0K2025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 566.8K2025 Q42026 Q1: 02026 Q12026 Q2: -50.0K2026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

207 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
ORESHACK KURTGeneral Counsel Sale −25.0K $5.10 $127K Jun 10, 2026 Form 4 ↗
ORESHACK KURTGeneral Counsel Sale −25.0K $5.06 $126K Jun 9, 2026 Form 4 ↗
LUCIER GREGORY TDirector Gift +46.3K $0.00 $0 Jun 9, 2026 Form 4 ↗
LUCIER GREGORY TDirector Gift −46.3K $0.00 $0 Jun 9, 2026 Form 4 ↗
Brust BerndChief Executive Officer · Director Tax withholding −351.0K $5.02 $1.8M Jun 8, 2026 Form 4 ↗
GRAY SUSANNAHDirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
MARKER LUKE JOSEPHDirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
CUNNINGHAM SEAN LAURENCEDirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
DeFord John ADirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
MIHAS CONSTANTINE SDirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
LUCIER GREGORY TDirector Grant / award Amended +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
LUCIER GREGORY TDirector Grant / award +46.3K $4.38 $203K May 26, 2026 Form 4 ↗
ECKERT R ANDREWDirector Grant / award +46.3K $0.00 $0 May 26, 2026 Form 4 ↗
ORESHACK KURTGeneral Counsel Grant / award +776 $2.84 $2K May 15, 2026 Form 4 ↗
Dolan ChristineSee Remarks Grant / award +5,006 $1.79 $9K May 15, 2026 Form 4 ↗
ORESHACK KURTGeneral Counsel Tax withholding −40.0K $3.08 $123K Mar 16, 2026 Form 4 ↗
Dolan ChristineSee Remarks Tax withholding −28.7K $3.08 $88K Mar 16, 2026 Form 4 ↗
ORESHACK KURTGeneral Counsel Tax withholding −31.9K $3.69 $118K Jan 15, 2026 Form 4 ↗
Dolan ChristineSee Remarks Tax withholding −28.9K $3.69 $107K Jan 15, 2026 Form 4 ↗
LUCIER GREGORY TDirector Purchase +48.5K $3.67 $178K Dec 8, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding MRVI · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
3.7M$23.1M0.00%Jun 30, 2026
First Eagle Small Cap Opportunity Fund
First Eagle Funds
3.2M$21.3M0.73%Jul 31, 2026
iShares Russell 2000 ETF
iShares Trust
3.0M$18.5M0.02%Jun 30, 2026
General American Investors Company, Inc.1.7M$10.7M0.62%Jun 30, 2026
Nuveen Quant Small Cap Equity Fund
TIAA-CREF Funds
1.6M$10.5M0.26%Jul 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.5M$9.1M0.01%Jun 30, 2026
Fidelity Small Cap Growth Fund
Fidelity Securities Fund
1.3M$8.3M0.09%Jul 31, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
1.2M$8.1M0.02%Jul 31, 2026
Meridian Contrarian Fund
Meridian Fund Inc
1.3M$8.0M1.17%Jun 30, 2026
ROYCE MICRO-CAP TRUST, INC.1.1M$7.1M0.78%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list MRVI's shares (CUSIP 56600D107), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Israel A. EnglanderSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
    Sep 29, 2026 · ↗
  • Millennium Group Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
    Sep 29, 2026 · ↗
  • Millennium Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
    Sep 29, 2026 · ↗
  • Joshua WoolSCHEDULE 13G/A · passive (13G) · 45.0K shares0.0%
    Aug 13, 2026 · ↗
  • Matthew BarkoffSCHEDULE 13G/A · passive (13G) · 290.1K shares0.2%
    Aug 13, 2026 · ↗
  • Stuart FeldmanSCHEDULE 13G/A · passive (13G) · 3.7M shares2.5%
    Aug 13, 2026 · ↗
  • JD Squared Capital II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
    Aug 13, 2026 · ↗
  • JD Squared Holdings II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
    Aug 13, 2026 · ↗
  • Hudson View Capital LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
    Aug 13, 2026 · ↗
  • Hudson View Holdings LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
    Aug 13, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming MARAVAI LIFESCIENCES HOLDINGS, INC. as client

No lobbying filings found naming MARAVAI LIFESCIENCES HOLDINGS, INC. as the client.

Government Contracts

Federal awards to MARAVAI LIFESCIENCES HOLDINGS, INC. · USAspending

No federal contract awards found for MARAVAI LIFESCIENCES HOLDINGS, INC..

U.S. Patents

Recent USPTO applications naming MARAVAI LIFESCIENCES HOLDINGS, INC.

No USPTO patent applications found for MARAVAI LIFESCIENCES HOLDINGS, INC..

Annual Financials

From MRVI's 10-K filings · XBRL

No annual XBRL figures on record for MRVI. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history

No stock splits in MRVI's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 1.02, 2.03, 7.01, 9.01Material agreement · Termination of agreement · Direct financial obligationJun 3, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 29, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About MARAVAI LIFESCIENCES HOLDINGS, INC.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSAN DIEGO, CA
IncorporatedDE